Answer
Yes, anaphylaxis has been reported with sebelipase alfa, so appropriate medical support must be readily available during administration, and severe reactions require immediate stopping of the infusion and appropriate medical treatment.
Sources for this answer
- KANUMA 2mg/ml concentrate solutionAlexion Pharma UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 9Document updated
Sources checked